The Group I MGlu Receptor Agonist DHPG Induces a Novel Form of LTD in the CA1 Region of the Hippocampus
Overview
Pharmacology
Affiliations
The group I specific metabotropic glutamate (mGlu) receptor agonist (RS)-3,5-dihydroxyphenylglycine (DHPG) (100 microM, 10 min) induced long-term depression (LTD) of synaptic transmission in the CA1 region of adult rat hippocampal slices, measured using a grease-gap recording technique. In "normal" (1 mM Mg2+-containing) medium, LTD (measured 30 min after washout of DHPG) was small (13+/-3%), but LTD was enhanced if DHPG was applied when the tissue was made hyperexcitable, either by omitting Mg2+ from the perfusate (35+/-3%) or by adding the GABA(A) receptor antagonist picrotoxin (29+/-2%). The N-methyl-D-aspartate (NMDA) receptor antagonist AP5 (100 microM) substantially reduced the generation of DHPG-induced LTD in Mg2+-free medium, but had little effect on LTD induced in the presence of picrotoxin. In Mg2+-free medium, the threshold concentration of DHPG required to induce LTD was between 1 and 3 microM. Neither agonists specific for group II (100 nM DCG-IV or 1 microM LY354740) or group III (10 microM L-AP4) mGlu receptors or a combined group I and II agonist (30-100 microM (1S,3R)-ACPD) induced LTD. However, an agonist (1 mM CHPG) which activates mGlu5 but not mGlu1 receptors did induce LTD. Surprisingly, DHPG-induced LTD was reversed by mGlu receptor antagonists, applied hours after washout of DHPG. DHPG-induced LTD did not occlude with LTD induced by synaptic activation (1200 stimuli delivered at 2 Hz), in Mg2+-free medium. These data show that activation of group I mGlu receptors (probably mGlu5) can induce LTD and that this mGlu receptor-mediated LTD may, or may not, require activation of NMDA receptors, depending on the experimental conditions.
Kos J, Langiu M, Hellyer S, Gregory K ACS Pharmacol Transl Sci. 2024; 7(12):3671-3690.
PMID: 39698283 PMC: 11651194. DOI: 10.1021/acsptsci.4c00213.
Synaptopodin: a key regulator of Hebbian plasticity.
Wu P, Inglebert Y, McKinney R Front Cell Neurosci. 2024; 18:1482844.
PMID: 39569068 PMC: 11576213. DOI: 10.3389/fncel.2024.1482844.
Ducote A, Voglewede R, Mostany R J Neurosci. 2024; 44(50).
PMID: 39448263 PMC: 11638818. DOI: 10.1523/JNEUROSCI.1378-24.2024.
Wu Q, Lin L, Lu K, Deng S, Li W, Xu Y Exp Mol Med. 2024; 56(8):1763-1775.
PMID: 39085354 PMC: 11371825. DOI: 10.1038/s12276-024-01285-0.
Holl N, Heerdegen M, Zschorlich V, Kohling R, Kirschstein T Brain Sci. 2024; 14(6).
PMID: 38928603 PMC: 11202050. DOI: 10.3390/brainsci14060603.